Manhasset Womens Coalition Against Breast Cancer is categorized under Family Practice Doctors in Manhasset, NY and active since 2009.
Manhasset Womens Coalition Against Breast Cancer was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Christine Mccarty at the company’s single location by writing to , Manhasset, New York NY 11030 or by phoning (516) 456-4463. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Manhasset Womens Coalition Against Breast Cancer |
Contact Person: | Christine Mccarty |
Phone Number: | (516) 456-4463 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2009 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Family Practice Doctors |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Manhasset Womens Coalition Against Breast Cancer was started in 2009 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Christine Mccarty for inquiries that concern Manhasset Womens Coalition Against Breast Cancer by calling the company number (516) 456-4463, as your correspondence is most welcome. Additionally, the physical location of the single location of Manhasset Womens Coalition Against Breast Cancer can be found at the coordinates as well as the street address in Manhasset, New York 11030.
For its online presence, you may visit Manhasset Womens Coalition Against Breast Cancer’s website at and engage with its social media outlets through on Twitter and on Facebook.